Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism

BACKGROUND: Valproic acid (VPA) is used as a first-line antiepileptic agent and is undergoing clinical trials for use as a treatment for many disorders. Mothers undergoing VPA treatment during early pregnancy reportedly show increased rates of autism among their offspring. The benefits of curcumin s...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Askar, Maha, Bhat, Ramesa Shafi, Selim, Manar, Al-Ayadhi, Laila, El-Ansary, Afaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424332/
https://www.ncbi.nlm.nih.gov/pubmed/28486989
http://dx.doi.org/10.1186/s12906-017-1763-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424332/
https://www.ncbi.nlm.nih.gov/pubmed/28486989
http://dx.doi.org/10.1186/s12906-017-1763-7

Ejemplares similares